Equities

Vivos Therapeutics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VVOS:NAQ

Vivos Therapeutics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.41
  • Today's Change0.01 / 0.71%
  • Shares traded59.86k
  • 1 Year change-59.37%
  • Beta6.9032
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

  • Revenue in USD (TTM)17.32m
  • Net income in USD-17.10m
  • Incorporated2020
  • Employees109.00
  • Location
    Vivos Therapeutics Inc7921 Southpark Plaza,, Suite 210LITTLETON 80120United StatesUSA
  • Fax+1 (302) 655-5049
  • Websitehttps://vivos.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
HeartSciences Inc8.67k-9.04m8.85m15.00--2.05--1,021.28-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
Tenon Medical Inc3.23m-12.81m9.44m27.00--4.35--2.92-2.76-2.760.57250.55760.27631.562.96119,740.70-109.47-174.04-149.09-976.4552.4034.39-396.26-788.171.70--0.00--11.92127.6112.25------
Bioelectronics Corp1.61m-289.82k9.88m9.00------6.14-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
SeaStar Medical Holding Corp881.00k-13.67m9.95m19.00--0.8209--11.29-16.43-16.430.68743.360.0876--6.1046,368.42-135.86---290.37--95.35---1,551.08--3.64--0.00------5.34------
Beyond Air Inc6.92m-31.00m10.12m61.00--0.9959--1.46-5.43-5.431.130.96510.19533.287.74113,508.20-90.33-81.28-107.51-103.401.82---462.58-4,167.724.77-13.320.7262--219.6721.6622.60--166.66--
QHSLab Inc2.61m-386.75k10.49m4.00------4.01-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
SINTX Technologies Inc1.27m-16.56m11.13m20.00--2.57--8.77-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
BioRegenx Inc1.93m-18.93m11.54m5.00------5.98-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
BioNano Genomics Inc28.72m-38.59m11.70m98.00--0.2247--0.4075-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
REMSleep Holdings Inc12.27k-3.01m11.95m6.00--49.56--974.29-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
Movano Inc500.00k-17.05m13.02m32.00------26.04-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
Vivos Therapeutics Inc17.32m-17.10m13.21m109.00--4.57--0.763-1.88-1.881.930.30630.8449--13.38158,871.60-83.45-85.27-120.33-138.5155.7467.27-98.77-108.16----0.7785--8.915.7018.02--26.46--
Trinity Biotech PLC (ADR)49.41m-35.91m13.46m401.00------0.2725-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
PAVmed Inc29.00k-595.00k14.40m39.000.90790.9163--496.67-20.47-20.470.015546.570.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
Vicarious Surgical Inc0.00-53.59m14.52m123.00--0.863-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
Data as of Mar 02 2026. Currency figures normalised to Vivos Therapeutics Inc's reporting currency: US Dollar USD

Institutional shareholders

6.79%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2025273.33k2.90%
DRW Securities LLCas of 31 Dec 2025115.91k1.23%
Geode Capital Management LLCas of 31 Dec 202556.29k0.60%
B. Riley Wealth Advisors, Inc.as of 31 Dec 202543.53k0.46%
Commonwealth Equity Services LLCas of 31 Dec 202540.50k0.43%
Vanguard Fiduciary Trust Co.as of 31 Dec 202530.83k0.33%
BlackRock Fund Advisorsas of 31 Dec 202527.82k0.30%
SSgA Funds Management, Inc.as of 31 Dec 202524.92k0.26%
Acorn Wealth Advisors LLCas of 31 Dec 202514.78k0.16%
UBS Securities LLCas of 31 Dec 202512.68k0.13%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.